NIH and NASA firm up space plans

In July, The Scientist linkurl:reported;http://www.the-scientist.com/news/display/53389/ on plans for a collaboration between NASA and NIH to conduct life science experiments aboard the International Space Station. Those plans, it seems, are taking off, with the two agencies holding a public signing at the Capitol tomorrow (Sept. 12) of a memorandum sealing the deal. The linkurl:release;http://www.nih.gov/news/pr/sep2007/od-10.htm from NIH does not specify projects for the collaboration, sayi

Written byAlla Katsnelson
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share
In July, The Scientist linkurl:reported;http://www.the-scientist.com/news/display/53389/ on plans for a collaboration between NASA and NIH to conduct life science experiments aboard the International Space Station. Those plans, it seems, are taking off, with the two agencies holding a public signing at the Capitol tomorrow (Sept. 12) of a memorandum sealing the deal. The linkurl:release;http://www.nih.gov/news/pr/sep2007/od-10.htm from NIH does not specify projects for the collaboration, saying only that plan "will help American scientists utilize the International Space Station." According to the NIH press office, many of the proposals for specific projects will likely come from the National Institute of Arthritis and Musculoskeletal and Skin Diseases, whose director, Stephen Katz, is the NIH liaison to NASA. Research will presumably be set to commence after completion of the space station in about three years. Attending tomorrow's meeting will be NIH director Elias Zerhouni, who will sign for NIH on the agreement, and at least one senator, Kay Bailey Hutchison (R-Texas), a long-time champion of space science and member of the Science and Space Subcommittee of the Senate Commerce Committee. Have thoughts about biomedical research in space? Leave a linkurl:comment;http://prod27.the-scientist.com/forum/addcomment/53582/ and let us know.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies